Cargando…
Possible immunotherapeutic potentiation with D-Fraction in prostate cancer cells
BACKGROUND: Prostate cancer remains the most common malignancy among elderly men and the second leading cause of cancer death in the United States. Although several conventional therapies are currently available, they have a low efficacy and the more effective treatment modalities need to be establi...
Autores principales: | Pyo, Paul, Louie, Brandon, Rajamahanty, Srinivas, Choudhury, Muhammad, Konno, Sensuke |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613393/ https://www.ncbi.nlm.nih.gov/pubmed/19055833 http://dx.doi.org/10.1186/1756-8722-1-25 |
Ejemplares similares
-
Possible disease remission in patient with invasive bladder cancer with D-fraction regimen
por: Rajamahanty, Srinivas, et al.
Publicado: (2009) -
Growth inhibition of androgen-responsive prostate cancer cells with brefeldin A targeting cell cycle and androgen receptor
por: Rajamahanty, Srinivas, et al.
Publicado: (2010) -
Synergistic potentiation of D-fraction with vitamin C as possible alternative approach for cancer therapy
por: Konno, Sensuke
Publicado: (2009) -
Possible hypoglycemic action of SX-fraction targeting insulin signal transduction pathway
por: Konno, Sensuke, et al.
Publicado: (2013) -
SX-fraction: Promise for novel treatment of type 2 diabetes
por: Konno, Sensuke
Publicado: (2020)